skip to main content

DOE PAGESDOE PAGES

Title: Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Publication Date:
Grant/Contract Number:
AC52-06NA25396
Type:
Publisher's Accepted Manuscript
Journal Name:
The Lancet Infectious Diseases
Additional Journal Information:
Journal Volume: 15; Journal Issue: 10; Related Information: CHORUS Timestamp: 2017-10-04 16:33:54; Journal ID: ISSN 1473-3099
Publisher:
Elsevier
Sponsoring Org:
USDOE
Country of Publication:
Country unknown/Code not available
Language:
English
OSTI Identifier:
1357305